Children with major congenital anomalies often require lifelong access to health and social care services. Estimating future numbers of affected individuals can aid health and social care planning. This study aimed to estimate the number of children aged 0-15 years living with spina bifida or Down syndrome in England and Wales by 2020. Cases of spina bifida and Down syndrome born during 1998-2013 were identified from the Northern Congenital Abnormality Survey and the National Down Syndrome Cytogenetic Register, respectively. The number of infants born with spina bifida during 1998-2019 were estimated by applying the average prevalence rate in the North of England to actual and projected births in England and Wales. Poisson regression was performed to estimate the number of infants born with Down syndrome in England and Wales during 1998-2013 and 2004-2019. The numbers of children aged 0-15 living with spina bifida or Down syndrome in 2014 and in 2020 were then estimated by multiplying year-and age-specific survival estimates by the number of affected births. An estimated 956 children with isolated spina bifida, 623 children with spina bifida and hydrocephalus and 11,592 children with Down syndrome aged 0-15 years will be living in England and Wales by 2020, increases of 7.2%, 12.0% and 12.7% since 2014, respectively. Due to improvements in survival, an increase in population size and changes in maternal age distribution at delivery, we anticipate further increases in the number of children living with spina bifida or Down syndrome by 2020.
Introduction
Spina bifida occurs in 4 per 10,000 pregnancies in Europe, with approximately 31% of these resulting in live births.(1) Infant survival for children born with spina bifida has been reported as 71% in the UK (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) and 87% in the US (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) women entering pregnancy at advanced maternal age.(6) However, terminations of Down's syndrome pregnancies due to an increase and improvements in antenatal screening have caused the number of live births with Down's syndrome to remain constant(6, 7) Survival of affected individuals also improved over time. (3, 8, 9) . While several studies worldwide have reported the live birth prevalence and survival of Down syndrome and spina bifida, (8, (10) (11) (12) (13) (14) to our knowledge none have combined these estimates to predict the population size of children with these conditions. Spina bifida and Down syndrome are examples of severe structural and chromosomal congenital anomalies respectively, where the affected individuals require lifelong specialised health care. This can include: complex surgeries, out-patient follow-up and access to disability equipment and special education, all of which come at substantial financial and emotional cost to society and the family. (15) (16) (17) For example, a US study reported a 13-fold increase in private care expenditures for children with spina bifida compared to the general population.(18) Therefore, it is important to estimate the number of individuals living with these conditions in order to make some inferences on future costs. Given that the transition from pediatric to adult care occurs around age 16 in the UK, and children can require additional support in adaptation to changes in the service provision, it is important to estimate the number of children of this age living with these conditions. We estimated the number of children aged 0-15 years who will be living with spina bifida or Down syndrome in England and Wales by the beginning of 2020.
Patients and Methods

Data sources
The Northern Congenital Abnormality Survey (NorCAS) was a population-based register that collected data on cases of congenital anomalies delivered to women residing in the North of 
Case classification and inclusion
The NorCAS recorded text descriptions and WHO ICD-10 codes for up to six individual congenital anomalies per case (22). These were categorised into group (the organ system affected, e.g. 'nervous system'), subtype (the specific condition, e.g. 'spina bifida'), and syndrome (e.g. 'Di George syndrome') based on EUROCAT guidelines (23, 24) . Cases with more than one ICD code were assigned a primary diagnosis using an hierarchical approach Cases of Down syndrome with multiple congenital anomalies were included as the additional anomalies are likely to be part of the Down syndrome.
Statistical Analysis
Using Poisson regression models with year of birth as the explanatory variable, we found no There was no significant association between (continuous) maternal age at delivery and mortality (HR= 0.99, 95% CI: 0.97-1.02; p=0.617). Survival estimates conditioned on year of delivery are shown in Tables 1 and 2 .
Survivors
An estimated 956 and 623 children aged 0-15 years are expected to be living with isolated spina bifida or spina bifida with hydrocephalus by the beginning of 2020 (Table 2) , of whom approximately 307 and 209 will be aged 0-4, 366 and 242 will be aged 5-10, 283 and 173 will be aged 11-15, respectively. An estimated 11,592 children aged 0-15 years are expected to be living with Down syndrome in 2020 (Table 2) , of whom 3875 will be aged 0-4, 4321 will be aged 5-10 and 3396 will be aged 11-15 years old. The estimated case numbers are greater in 2020 than in 2014, when 892 children were living with isolated spina bifida, 556 with spina bifida and hydrocephalus and 10,285 with Down syndrome (Table I1) , estimated increases of 7.2% (n=64), 12.0% (n=67) and 12.7% (n=1,307) , respectively.
Sensitivity analysis
Had we assumed the rate of Down syndrome cases born between 2014-2019 was equal to the Compared to using the modelling methods, this was an excess of just one case.
Discussion
To our knowledge, this is the only study to predict future numbers of spina bifida and Down syndrome in England & Wales. We predict that compared to 2014, there will be a 12.7%, 7.2% and a 12.0% increase in the population of children aged 0-15 years living with Down syndrome, isolated spina bifida and spina bifida with hydrocephalus in England and Wales by 2020, respectively.
We used data from high quality population-based registers that are notified of cases from multiple sources, ensuring high case ascertainment. Survival estimates were derived from
NorCAS data linked to ONS death registrations, where 98% of cases were traced.(2) We used conditional survival estimates to account for temporal changes in survival and we used agespecific survival for more accurate estimates of the number of individuals living with the conditions. We examined spina bifida according to the co-occurrence of hydrocephalus, which is important given the difference in disease severity and therefore the different services and disability aids required by affected individuals. We also compared estimated case numbers of Down syndrome using two different methods, finding a discrepancy of only one case.
We We were only able to model maternal age categorically, which does not entirely capture the association with maternal age. For example, the categorisation of maternal age ≥35 does not account for the rising maternal age within this group, i.e. over time the fertility rate has been rising in mothers aged 40 and above. (36) This may explain why we identified an increasing trend in Down syndrome prevalence in mothers aged ≥35. Additionally, 11% of the Down syndrome cases had missing maternal age data. We assumed that this data was missing at random and therefore inflated the number of cases within each maternal age category. If the data was not missing at random (i.e. if the missingness occurred more for one maternal age category than for another), then this approach may mean our trends over time are slightly inaccurate. Given only 11% of cases had missing maternal age however, this is not likely to have had a great impact on the projections.
A previous study estimated the number of individuals living with Down syndrome in England and Wales by 2011 was 37,090, with 10,438 of these being aged ≤18.(37) For 2014, we estimated that there would have been 10,285 children aged 0-15 years, which suggests we estimated a higher number of individuals than the previous study. This was likely due to our different estimates of first year survival, which were greater in our study than in Wu et al's, which estimated survival by pooling rates from previous publications.
We estimate that the population of children aged 0-15 with spina bifida or Down syndrome will increase slightly from 2014. This increase is mainly due to the increasing number of Therefore, this estimation of future cases is important for planning specialised health and care services, including the associated costs. This is important given that children with spina bifida or Down syndrome have a 13-fold increase in private care expenditures compared to the general population of the US.(18, 38) Therefore, it is important to estimate the number of individuals living with these conditions in order to make some inferences on future costs. This is of particular importance given the changes in funding currently proposed in the UK and US health sectors.
Conclusions
Children with spina bifida and Down syndrome often have lifelong specialised health and social care needs. Our estimated increase in the numbers of affected individuals can aid healthcare planning and cost estimation to ensure these services are in place, which is particularly important given current austerity in the UK.
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